N. J. A. Jalil, “The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin”, J Pharm Pharm Sci, vol. 18, no. 3, pp. 474–483, Sep. 2015.